ArticleBlood advances2025

Inequalities in CAR T-cell therapy access for US patients with relapsed/refractory DLBCL: a SEER-Medicare data analysis.

Andrea P Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.